Hepion Pharmaceuticals
Why Robinhood?
You can watch HEPA and buy or sell other stocks, ETFs, and their options commission-free!About HEPA
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
HEPA Key Statistics
Stock Snapshot
With a market cap of 63.19M, Hepion Pharmaceuticals(HEPA) trades at $0.83. The stock has a price-to-earnings ratio of -0.90.
On 2026-03-17, Hepion Pharmaceuticals(HEPA) stock opened at —, reached a high of —, and a low of —.
The Hepion Pharmaceuticals(HEPA)'s current trading volume is 0, compared to an average daily volume of 325.66K.
During the past year, Hepion Pharmaceuticals(HEPA) stock moved between $0.26 at its lowest and $1.19 at its peak.
During the past year, Hepion Pharmaceuticals(HEPA) stock moved between $0.26 at its lowest and $1.19 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.